Product Update: Abece...

2024-04-16

Abciximab is an oral cell cycle protein-dependent kinase CDK4/6 inhibitor and the...

View Details

Product Update: Nilot...

2024-04-16

Nilotinib is a new type of targeted oncology drug, belongs to tyrosine kinase inh...

View Details

Product Update: Imati...

2024-03-19

Imatinib is a novel 2-anilinopyrimidine tyrosine kinase inhibitor that selectivel...

View Details

Product Update: Ibrut...

2023-12-04

Ibrutinib is a first-in-class oral Bruton's tyrosine kinase (BTK) inhibitor t...

View Details

Product Update: Pemet...

2023-12-04

Pemetrexed disodium is a therapeutic oncology drug successfully developed by Eli ...

View Details

Product Update: Perpe...

2023-01-06

Pipecilli is an oral cell cyclin-dependent kinases (CDKs) 4 and 6 inhibitor that ...

View Details